Destination-Therapy Ventricular Assist Device in Children: “The Future Is Now”

Nandi, 2015, Epidemiology and cost of heart failure in children, Cardiol Young, 25 Rossano, 2012, Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study, J Card Fail, 18, 459, 10.1016/j.cardfail.2012.03.001 Zafar, 2015, Pediatric heart transplant waiting list mortality in the era of ventricular assist devices, J Heart Lung Transplant, 34, 82, 10.1016/j.healun.2014.09.018 VanderPluym, 2014, Ventricular assist devices in children: progress with an orphan device application, Circulation, 129, 1530, 10.1161/CIRCULATIONAHA.113.005574 Rossano, 2016, Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: a report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS), J Heart Lung Transplant, 35, 585, 10.1016/j.healun.2016.01.1228 VanderPluym, 2018, Outcomes of children supported with an intracorporeal continuous-flow left ventricular assist system, J Heart Lung Transplant, 38, 385, 10.1016/j.healun.2018.09.015 Morales, 2019, Third annual Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS) report: preimplant characteristics and outcomes, Ann Thorac Surg, 107, 993, 10.1016/j.athoracsur.2019.01.038 Purkey, 2018, Long-term pediatric ventricular assist device therapy: a case report of 2100+ days of support, ASAIO J, 64, e1, 10.1097/MAT.0000000000000546 Char, 2016, Can destination therapy be implemented in children with heart failure? A study of provider perceptions, Pediatr Transplant, 20, 819, 10.1111/petr.12747 Bonacchi, 2015, Mechanical ventricular assistance as destination therapy for end-stage heart failure: has it become a first line therapy?, Front Surg, 2, 35, 10.3389/fsurg.2015.00035 Park, 2005, Left ventricular assist devices as destination therapy: a new look at survival, J Thorac Cardiovasc Surg, 129, 9, 10.1016/j.jtcvs.2004.04.044 Rizzieri, 2008, Ethical challenges with the left ventricular assist device as a destination therapy, Philos Ethics Humanit Med, 3, 20, 10.1186/1747-5341-3-20 Makdisi, 2017, How to establish a successful destination therapy ventricular assist device program, J Thorac Dis, 9, 932, 10.21037/jtd.2017.03.139 Porepa, 2014, Destination therapy with left ventricular assist devices: for whom and when?, Can J Cardiol, 30, 296, 10.1016/j.cjca.2013.12.017 Goldstein, 2019, Third annual report from the ISHLT Mechanically Assisted Circulatory Support Registry: a comparison of centrifugal and axial continuous-flow left ventricular assist devices, J Heart Lung Transplant, 38, 352, 10.1016/j.healun.2019.02.004 Miller, 2015, Pediatric quality of life while supported with a ventricular assist device, Congenit Heart Dis, 10, E189, 10.1111/chd.12260 Adams, 2018, Quality of life with an LVAD: a misunderstood concept, Heart Lung, 47, 177, 10.1016/j.hrtlng.2018.02.003 Allen, 2012, Decision making in advanced heart failure: a scientific statement from the American Heart Association, Circulation, 125, 1928, 10.1161/CIR.0b013e31824f2173 Hollander, 2016, Compassionate deactivation of ventricular assist devices in pediatric patients, J Heart Lung Transplant, 35, 564, 10.1016/j.healun.2016.03.020 Dunlay, 2016, Dying with a left ventricular assist device as destination therapy, Circ Heart Fail, 9, 10.1161/CIRCHEARTFAILURE.116.003096 Fayssoil, 2010, Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics, Heart Fail Rev, 15, 103, 10.1007/s10741-009-9156-8 Connuck, 2008, Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry, Am Heart J, 155, 998, 10.1016/j.ahj.2008.01.018 Jin, 2019, Cardiopulmonary phenotypic discordance is common in Duchenne muscular dystrophy, Pediatr Pulmonol, 54, 186, 10.1002/ppul.24205 Iodice, 2015, Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learned, Neuromuscul Disord, 25, 19, 10.1016/j.nmd.2014.08.008 Fayssoil, 2017, Clinical profiles and prognosis of acute heart failure in adult patients with dystrophinopathies on home mechanical ventilation, ESC Heart Fail, 4, 527, 10.1002/ehf2.12165 Cheeran, 2017, Predictors of death in adults with duchenne muscular dystrophy–associated cardiomyopathy, J Am Heart Assoc, 6 Niebler, 2014, Use of a Heartware ventricular assist device in a patient with failed fontan circulation, Ann Thorac Surg, 97, e115, 10.1016/j.athoracsur.2013.11.075 Morales, 2011, A new era: use of an intracorporeal systemic ventricular assist device to support a patient with a failing Fontan circulation, J Thorac Cardiovasc Surg, 142, e138, 10.1016/j.jtcvs.2011.05.018 VanderPluym, 2011, The use of ventricular assist devices in pediatric patients with univentricular hearts, J Thorac Cardiovasc Surg, 141, 588, 10.1016/j.jtcvs.2010.06.038 VanderPluym, 2016, The role of continuous flow ventricular assist device for destination therapy in children: can it work or is it a bridge too far?, Prog Pediatr Cardiol, 40, 25, 10.1016/j.ppedcard.2016.01.008 Jaquiss, 2016, Is four stage management the future of univentricular hearts? Destination therapy in the young, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 19, 50, 10.1053/j.pcsu.2015.12.004 Giridharan, 2014, Cavopulmonary assist for the failing Fontan circulation, ASAIO J, 60, 707, 10.1097/MAT.0000000000000135 Derk, 2014, Novel techniques of mechanical circulatory support for the right heart and Fontan circulation, Int J Cardiol, 176, 828, 10.1016/j.ijcard.2014.08.012 Lacour-Gayet, 2009, An artificial right ventricle for failing fontan: in vitro and computational study, Ann Thorac Surg, 88, 170, 10.1016/j.athoracsur.2009.03.091 Rossano, 2014, Successful use of the total artificial heart in the failing fontan circulation, Ann Thorac Surg, 97, 1438, 10.1016/j.athoracsur.2013.06.120 Burki, 2017, Pediatric ventricular assist devices: current challenges and future prospects, Vasc Health Risk Manag, 2017, 177, 10.2147/VHRM.S82379